FLORTEKXIN 300 mg/ml + 16.5 mg/ml

Data sheet :

Product Description

Composition
Each ml contains 300 mg of Florfenicol + 16.5 mg of Flunixin

Treatment of respiratory infections caused by Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma bovis, associated with pyrexia.

Subcutaneous use.
40 mg/kg florfenicol and 2.2 mg/kg flunixin (2 ml/15 kg) to be administered by a single subcutaneous injection. The dose volume given at any one injection should not exceed 10 ml.

For more information, check your national SPCs.

Cattle

Meat and offal: 46 days.
Milk: Not authorised for use in animals producing milk for human consumption. Do not use in pregnant animals which are intended to produce milk for human consumption within 2 months of expected parturition.

Vials of 100 ml and 250 ml.

Comunicación Farmacovigilancia

Pharmacovigilance Communication